SUBSEQUENT EVENTS (Details) |
3 Months Ended | 11 Months Ended | |||||
|---|---|---|---|---|---|---|---|
|
May 08, 2025
USD ($)
shares
|
May 18, 2023
USD ($)
shares
|
Jul. 27, 2022
USD ($)
shares
|
Jun. 29, 2021
USD ($)
shares
|
Mar. 31, 2026
USD ($)
shares
|
Mar. 31, 2026
USD ($)
shares
|
Mar. 09, 2026
item
|
|
| Subsequent event | |||||||
| Shares issued (in shares) | shares | 30,093 | 57,961 | 143,750 | ||||
| Gross proceeds from stock issue | $ | $ 4,000,000 | $ 4,200,000 | $ 17,300,000 | ||||
| Equity Line of Credit Purchase Agreement | |||||||
| Subsequent event | |||||||
| Shares issued (in shares) | shares | 751,397 | ||||||
| Gross proceeds from stock issue | $ | $ 3,953,430 | ||||||
| Subsequent Events | |||||||
| Subsequent event | |||||||
| Number of patients enrolled in program having at least two recurrences in 12 months | item | 20 | ||||||
| Subsequent Events | Equity Line of Credit Purchase Agreement | |||||||
| Subsequent event | |||||||
| Shares issued (in shares) | shares | 482,038 | 1,233,434 | |||||
| Gross proceeds from stock issue | $ | $ 1,000,000 | $ 4,900,000 |
| X | ||||||||||
- Definition The number of patients enrolled in the clinical trail program who have experienced at least two recurrences in twelve months. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|